nodes	percent_of_prediction	percent_of_DWPC	metapath
Sodium stibogluconate—Clotting—Temozolomide—malignant glioma	0.0332	0.0769	CcSEcCtD
Sodium stibogluconate—TOP1—Caspase Cascade in Apoptosis—TNFSF10—malignant glioma	0.0328	0.0797	CbGpPWpGaD
Sodium stibogluconate—TOP1—retina—malignant glioma	0.0322	0.205	CbGeAlD
Sodium stibogluconate—TOP1—telencephalon—malignant glioma	0.0296	0.189	CbGeAlD
Sodium stibogluconate—TOP1—Circadian rythm related genes—NTRK3—malignant glioma	0.0279	0.0677	CbGpPWpGaD
Sodium stibogluconate—TOP1—Caspase Cascade in Apoptosis—PTK2—malignant glioma	0.0249	0.0604	CbGpPWpGaD
Sodium stibogluconate—TOP1—medulla oblongata—malignant glioma	0.0233	0.148	CbGeAlD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—STMN1—malignant glioma	0.0232	0.0563	CbGpPWpGaD
Sodium stibogluconate—TOP1—midbrain—malignant glioma	0.0213	0.136	CbGeAlD
Sodium stibogluconate—TOP1—spinal cord—malignant glioma	0.0207	0.132	CbGeAlD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—PLK1—malignant glioma	0.0176	0.0427	CbGpPWpGaD
Sodium stibogluconate—Lung disorder—Temozolomide—malignant glioma	0.0167	0.0388	CcSEcCtD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—WT1—malignant glioma	0.0167	0.0405	CbGpPWpGaD
Sodium stibogluconate—TOP1—cerebellum—malignant glioma	0.0164	0.105	CbGeAlD
Sodium stibogluconate—Necrosis—Carmustine—malignant glioma	0.0156	0.0362	CcSEcCtD
Sodium stibogluconate—Abscess—Carmustine—malignant glioma	0.0155	0.0359	CcSEcCtD
Sodium stibogluconate—Coagulopathy—Temozolomide—malignant glioma	0.0152	0.0353	CcSEcCtD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—PML—malignant glioma	0.0149	0.0361	CbGpPWpGaD
Sodium stibogluconate—TOP1—Caspase Cascade in Apoptosis—BCL2—malignant glioma	0.0144	0.035	CbGpPWpGaD
Sodium stibogluconate—TOP1—Circadian rythm related genes—PML—malignant glioma	0.0143	0.0346	CbGpPWpGaD
Sodium stibogluconate—Extravasation—Carmustine—malignant glioma	0.014	0.0326	CcSEcCtD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—TOP2A—malignant glioma	0.0136	0.033	CbGpPWpGaD
Sodium stibogluconate—TOP1—brain—malignant glioma	0.0134	0.0852	CbGeAlD
Sodium stibogluconate—TOP1—Circadian rythm related genes—TOP2A—malignant glioma	0.013	0.0317	CbGpPWpGaD
Sodium stibogluconate—TOP1—Caspase Cascade in Apoptosis—CASP3—malignant glioma	0.0127	0.0309	CbGpPWpGaD
Sodium stibogluconate—Sepsis—Carmustine—malignant glioma	0.0106	0.0247	CcSEcCtD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—NTRK1—malignant glioma	0.0106	0.0257	CbGpPWpGaD
Sodium stibogluconate—Phlebitis—Carmustine—malignant glioma	0.0103	0.0239	CcSEcCtD
Sodium stibogluconate—TOP1—Circadian rythm related genes—NTRK1—malignant glioma	0.0101	0.0246	CbGpPWpGaD
Sodium stibogluconate—Swelling—Carmustine—malignant glioma	0.0101	0.0234	CcSEcCtD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—BRCA2—malignant glioma	0.00982	0.0239	CbGpPWpGaD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—CDKN2B—malignant glioma	0.00974	0.0236	CbGpPWpGaD
Sodium stibogluconate—TOP1—Caspase Cascade in Apoptosis—TNF—malignant glioma	0.00925	0.0225	CbGpPWpGaD
Sodium stibogluconate—Hyponatraemia—Carmustine—malignant glioma	0.00893	0.0207	CcSEcCtD
Sodium stibogluconate—TOP1—Circadian rythm related genes—NCOR1—malignant glioma	0.00887	0.0215	CbGpPWpGaD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—PDGFRA—malignant glioma	0.00885	0.0215	CbGpPWpGaD
Sodium stibogluconate—Hypokalaemia—Carmustine—malignant glioma	0.0081	0.0188	CcSEcCtD
Sodium stibogluconate—Dehydration—Temozolomide—malignant glioma	0.00799	0.0185	CcSEcCtD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—FGFR1—malignant glioma	0.0079	0.0192	CbGpPWpGaD
Sodium stibogluconate—Hypokalaemia—Temozolomide—malignant glioma	0.00782	0.0181	CcSEcCtD
Sodium stibogluconate—Dysphagia—Carmustine—malignant glioma	0.00769	0.0178	CcSEcCtD
Sodium stibogluconate—Abdominal distension—Temozolomide—malignant glioma	0.00748	0.0173	CcSEcCtD
Sodium stibogluconate—Dysphagia—Temozolomide—malignant glioma	0.00743	0.0172	CcSEcCtD
Sodium stibogluconate—Sweating increased—Temozolomide—malignant glioma	0.00724	0.0168	CcSEcCtD
Sodium stibogluconate—Bronchitis—Temozolomide—malignant glioma	0.00715	0.0166	CcSEcCtD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—BAD—malignant glioma	0.00708	0.0172	CbGpPWpGaD
Sodium stibogluconate—TOP1—Caspase Cascade in Apoptosis—AKT1—malignant glioma	0.00689	0.0167	CbGpPWpGaD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—APC—malignant glioma	0.00686	0.0167	CbGpPWpGaD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—EGF—malignant glioma	0.00678	0.0165	CbGpPWpGaD
Sodium stibogluconate—Renal failure—Carmustine—malignant glioma	0.00674	0.0156	CcSEcCtD
Sodium stibogluconate—TOP1—Circadian rythm related genes—PPARG—malignant glioma	0.00636	0.0154	CbGpPWpGaD
Sodium stibogluconate—Hypoaesthesia—Carmustine—malignant glioma	0.00612	0.0142	CcSEcCtD
Sodium stibogluconate—Hypoaesthesia—Temozolomide—malignant glioma	0.00592	0.0137	CcSEcCtD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—FGF2—malignant glioma	0.00577	0.014	CbGpPWpGaD
Sodium stibogluconate—Arrhythmia—Carmustine—malignant glioma	0.0055	0.0127	CcSEcCtD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—BCL2—malignant glioma	0.00548	0.0133	CbGpPWpGaD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—MDM2—malignant glioma	0.0054	0.0131	CbGpPWpGaD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—RAF1—malignant glioma	0.00538	0.0131	CbGpPWpGaD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—ERBB2—malignant glioma	0.00533	0.0129	CbGpPWpGaD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—PTGS2—malignant glioma	0.00521	0.0126	CbGpPWpGaD
Sodium stibogluconate—Dysgeusia—Temozolomide—malignant glioma	0.00507	0.0118	CcSEcCtD
Sodium stibogluconate—Vision blurred—Carmustine—malignant glioma	0.00505	0.0117	CcSEcCtD
Sodium stibogluconate—Vision blurred—Temozolomide—malignant glioma	0.00488	0.0113	CcSEcCtD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—CASP3—malignant glioma	0.00483	0.0117	CbGpPWpGaD
Sodium stibogluconate—Convulsion—Carmustine—malignant glioma	0.00464	0.0108	CcSEcCtD
Sodium stibogluconate—Palpitations—Temozolomide—malignant glioma	0.00458	0.0106	CcSEcCtD
Sodium stibogluconate—Chest pain—Carmustine—malignant glioma	0.00456	0.0106	CcSEcCtD
Sodium stibogluconate—Anxiety—Carmustine—malignant glioma	0.00455	0.0105	CcSEcCtD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—PTEN—malignant glioma	0.00454	0.011	CbGpPWpGaD
Sodium stibogluconate—Convulsion—Temozolomide—malignant glioma	0.00449	0.0104	CcSEcCtD
Sodium stibogluconate—Anxiety—Temozolomide—malignant glioma	0.00439	0.0102	CcSEcCtD
Sodium stibogluconate—Oedema—Carmustine—malignant glioma	0.00437	0.0101	CcSEcCtD
Sodium stibogluconate—TOP1—Circadian rythm related genes—PTEN—malignant glioma	0.00436	0.0106	CbGpPWpGaD
Sodium stibogluconate—Infection—Carmustine—malignant glioma	0.00434	0.0101	CcSEcCtD
Sodium stibogluconate—Tachycardia—Carmustine—malignant glioma	0.00427	0.00989	CcSEcCtD
Sodium stibogluconate—Anaphylactic shock—Temozolomide—malignant glioma	0.00423	0.0098	CcSEcCtD
Sodium stibogluconate—Oedema—Temozolomide—malignant glioma	0.00423	0.0098	CcSEcCtD
Sodium stibogluconate—Infection—Temozolomide—malignant glioma	0.0042	0.00973	CcSEcCtD
Sodium stibogluconate—Anorexia—Carmustine—malignant glioma	0.00417	0.00966	CcSEcCtD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—VEGFA—malignant glioma	0.0041	0.00996	CbGpPWpGaD
Sodium stibogluconate—Hypotension—Carmustine—malignant glioma	0.00409	0.00947	CcSEcCtD
Sodium stibogluconate—Hyperhidrosis—Temozolomide—malignant glioma	0.00408	0.00947	CcSEcCtD
Sodium stibogluconate—Anorexia—Temozolomide—malignant glioma	0.00403	0.00934	CcSEcCtD
Sodium stibogluconate—Paraesthesia—Carmustine—malignant glioma	0.00393	0.0091	CcSEcCtD
Sodium stibogluconate—Dyspnoea—Carmustine—malignant glioma	0.0039	0.00904	CcSEcCtD
Sodium stibogluconate—Decreased appetite—Carmustine—malignant glioma	0.0038	0.00881	CcSEcCtD
Sodium stibogluconate—Paraesthesia—Temozolomide—malignant glioma	0.00379	0.0088	CcSEcCtD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—MYC—malignant glioma	0.00377	0.00916	CbGpPWpGaD
Sodium stibogluconate—Dyspnoea—Temozolomide—malignant glioma	0.00377	0.00873	CcSEcCtD
Sodium stibogluconate—Constipation—Carmustine—malignant glioma	0.00374	0.00867	CcSEcCtD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—EGFR—malignant glioma	0.00369	0.00896	CbGpPWpGaD
Sodium stibogluconate—Decreased appetite—Temozolomide—malignant glioma	0.00367	0.00852	CcSEcCtD
Sodium stibogluconate—Fatigue—Temozolomide—malignant glioma	0.00364	0.00845	CcSEcCtD
Sodium stibogluconate—Constipation—Temozolomide—malignant glioma	0.00361	0.00838	CcSEcCtD
Sodium stibogluconate—Gastrointestinal pain—Carmustine—malignant glioma	0.00358	0.00829	CcSEcCtD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—TNF—malignant glioma	0.00352	0.00854	CbGpPWpGaD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—KRAS—malignant glioma	0.00349	0.00847	CbGpPWpGaD
Sodium stibogluconate—Abdominal pain—Carmustine—malignant glioma	0.00346	0.00801	CcSEcCtD
Sodium stibogluconate—Body temperature increased—Carmustine—malignant glioma	0.00346	0.00801	CcSEcCtD
Sodium stibogluconate—Gastrointestinal pain—Temozolomide—malignant glioma	0.00346	0.00801	CcSEcCtD
Sodium stibogluconate—Urticaria—Temozolomide—malignant glioma	0.00336	0.00778	CcSEcCtD
Sodium stibogluconate—Abdominal pain—Temozolomide—malignant glioma	0.00334	0.00774	CcSEcCtD
Sodium stibogluconate—Body temperature increased—Temozolomide—malignant glioma	0.00334	0.00774	CcSEcCtD
Sodium stibogluconate—Hypersensitivity—Carmustine—malignant glioma	0.00322	0.00747	CcSEcCtD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—PIK3CA—malignant glioma	0.0032	0.00778	CbGpPWpGaD
Sodium stibogluconate—Asthenia—Carmustine—malignant glioma	0.00314	0.00727	CcSEcCtD
Sodium stibogluconate—Hypersensitivity—Temozolomide—malignant glioma	0.00311	0.00722	CcSEcCtD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—TP53—malignant glioma	0.0031	0.00753	CbGpPWpGaD
Sodium stibogluconate—Asthenia—Temozolomide—malignant glioma	0.00303	0.00703	CcSEcCtD
Sodium stibogluconate—Diarrhoea—Carmustine—malignant glioma	0.00299	0.00694	CcSEcCtD
Sodium stibogluconate—Pruritus—Temozolomide—malignant glioma	0.00299	0.00693	CcSEcCtD
Sodium stibogluconate—TOP1—Circadian rythm related genes—TP53—malignant glioma	0.00298	0.00722	CbGpPWpGaD
Sodium stibogluconate—Dizziness—Carmustine—malignant glioma	0.00289	0.0067	CcSEcCtD
Sodium stibogluconate—Diarrhoea—Temozolomide—malignant glioma	0.00289	0.0067	CcSEcCtD
Sodium stibogluconate—Dizziness—Temozolomide—malignant glioma	0.00279	0.00648	CcSEcCtD
Sodium stibogluconate—Vomiting—Carmustine—malignant glioma	0.00278	0.00645	CcSEcCtD
Sodium stibogluconate—Rash—Carmustine—malignant glioma	0.00276	0.00639	CcSEcCtD
Sodium stibogluconate—Dermatitis—Carmustine—malignant glioma	0.00275	0.00639	CcSEcCtD
Sodium stibogluconate—Headache—Carmustine—malignant glioma	0.00274	0.00635	CcSEcCtD
Sodium stibogluconate—Vomiting—Temozolomide—malignant glioma	0.00269	0.00623	CcSEcCtD
Sodium stibogluconate—Rash—Temozolomide—malignant glioma	0.00266	0.00618	CcSEcCtD
Sodium stibogluconate—Dermatitis—Temozolomide—malignant glioma	0.00266	0.00617	CcSEcCtD
Sodium stibogluconate—Headache—Temozolomide—malignant glioma	0.00265	0.00614	CcSEcCtD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—AKT1—malignant glioma	0.00262	0.00635	CbGpPWpGaD
Sodium stibogluconate—Nausea—Carmustine—malignant glioma	0.0026	0.00602	CcSEcCtD
Sodium stibogluconate—Nausea—Temozolomide—malignant glioma	0.00251	0.00582	CcSEcCtD
